152 related articles for article (PubMed ID: 6684947)
1. Investigation of diurnal changes in the disposition of theophylline.
Taylor DR; Duffin D; Kinney CD; McDevitt DG
Br J Clin Pharmacol; 1983 Oct; 16(4):413-6. PubMed ID: 6684947
[TBL] [Abstract][Full Text] [Related]
2. Chronopharmacokinetics of theophylline after sustained release and intravenous administration to adults.
Jonkman JH; van der Boon WJ; Balant LP; Schoenmaker R; Holtkamp A
Eur J Clin Pharmacol; 1984; 26(2):215-22. PubMed ID: 6723760
[TBL] [Abstract][Full Text] [Related]
3. Differences in steady-state plasma levels between aminophylline and theophylline sustained-release micropellets after repeated circadian dosing.
Schulz HU; Steinijans VW; Gabel H
Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):621-5. PubMed ID: 6500759
[TBL] [Abstract][Full Text] [Related]
4. Temporal variation in the disposition of theophylline and its metabolites.
St-Pierre MV; Spino M; Isles AF; Tesoro A; MacLeod SM
Clin Pharmacol Ther; 1985 Jul; 38(1):89-95. PubMed ID: 4039998
[TBL] [Abstract][Full Text] [Related]
5. Conversion from intravenous to oral dosing using sustained-release theophylline tablets.
Stein GE; Haughey DB; Ross RJ; Vakoutis J
Drug Intell Clin Pharm; 1982 Oct; 16(10):772-4. PubMed ID: 7140514
[TBL] [Abstract][Full Text] [Related]
6. Circadian changes in the absorption and elimination of theophylline in patients with bronchial obstruction.
Uematsu T; Follath F; Vozeh S
Eur J Clin Pharmacol; 1986; 30(3):309-12. PubMed ID: 3732366
[TBL] [Abstract][Full Text] [Related]
7. Theophylline kinetics in acute pulmonary edema.
Piafsky KM; Sitar DS; Rangno RE; Ogilvie RI
Clin Pharmacol Ther; 1977 Mar; 21(3):310-6. PubMed ID: 837650
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
Schuppan D; Molz KH; Staib AH; Rietbrock N
Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
[TBL] [Abstract][Full Text] [Related]
9. Reliability of theophylline clearance in determining chronic oral dosage regimens.
Slotfeldt ML; Johnson CE; Grambau G; Weg JG
Am J Hosp Pharm; 1979 Jan; 36(1):66-8. PubMed ID: 758787
[TBL] [Abstract][Full Text] [Related]
10. Theophylline concentration following equal doses of intravenous aminophylline and oral theophylline in preterm infants.
al-Omran A; al-Alaiyan S
Am J Perinatol; 1997 Mar; 14(3):147-9. PubMed ID: 9259917
[TBL] [Abstract][Full Text] [Related]
11. Influence of morning or evening administration on absorption of theophylline.
Su YM; Cheng TP; Yeh TW; Wen CY; Wang DI
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
[TBL] [Abstract][Full Text] [Related]
12. Time-dependent absorption of theophylline in man.
Watanabe H; Nakano S; Nagai K; Ogawa N
J Clin Pharmacol; 1984; 24(11-12):509-14. PubMed ID: 6511990
[TBL] [Abstract][Full Text] [Related]
13. Plasma concentrations of theophylline and quinine in healthy volunteers following oral administration of a fixed drug combination.
Dieterich HA; Messer W; Jaehnchen E
Arzneimittelforschung; 1984; 34(4):520-2. PubMed ID: 6540112
[TBL] [Abstract][Full Text] [Related]
14. Dose conversion from aminophylline to theophylline in preterm infants.
Reese J; Prentice G; Yu VY
Arch Dis Child Fetal Neonatal Ed; 1994 Jul; 71(1):F51-2. PubMed ID: 8092873
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability and diurnal variation in absorption of sustained release theophylline in asthmatic children.
Coulthard KP; Birkett DJ; Lines DR; Grgurinovich N; Grygiel JJ
Eur J Clin Pharmacol; 1983; 25(5):667-72. PubMed ID: 6686557
[TBL] [Abstract][Full Text] [Related]
16. Circadian rhythm in theophylline disposition during a constant-rate intravenous infusion of aminophylline in the dog.
Rackley RJ; Meyer MC; Straughn AB
J Pharm Sci; 1988 Aug; 77(8):658-61. PubMed ID: 3210152
[TBL] [Abstract][Full Text] [Related]
17. Circadian variation in plasma theophylline concentrations during maintenance therapy with a sustained-release preparation in patients with obstructive airways disease.
Taylor DR; Duffin D; Kinney CD; McDevitt DG
Br J Clin Pharmacol; 1984 Jul; 18(1):27-30. PubMed ID: 6743488
[TBL] [Abstract][Full Text] [Related]
18. Comparative pharmacokinetics of theophylline and aminophylline in man.
Aslaksen A; Bakke OM; Vigander T
Br J Clin Pharmacol; 1981 Mar; 11(3):269-73. PubMed ID: 7213528
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic disposition of an immediate-release aminophylline and a sustained-release theophylline formulation in the horse.
Goetz TE; Munsiff IJ; McKiernan BC
J Vet Pharmacol Ther; 1989 Dec; 12(4):369-77. PubMed ID: 2614856
[TBL] [Abstract][Full Text] [Related]
20. Individualized aminophylline therapy in patients with obstructive airway disease: oral dosage prediction from an intravenous test dose.
Horai Y; Ishizaki T; Sasaki T; Watanabe M; Kabe J
Eur J Clin Pharmacol; 1982; 23(2):111-21. PubMed ID: 7140800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
